期刊文献+

垂体瘤转化基因诱导血管内皮生长因子的分子机制 被引量:1

Molecular mechanisms underlying the induction of vascular endothelial growth factor expression by pituitary tumor transforming gene
原文传递
导出
摘要 血管内皮生长因子是一个强大的促血管新生的生长因子,而垂体瘤转化基因可以通过诱导VEGF的表达进而促进肿瘤血管新生。与垂体瘤转化基因结合因子及Spl蛋白结合后,垂体瘤转化基因不仅能反式激活DNA结合抑制因子-3和成纤维细胞生长因子-2,而且可通过其他途径调节基质水解蛋白酶-2、凝血酶反应蛋白-1以及硫氧还蛋白-1的转录,上述因子又参与了垂体瘤转化基因诱导血管内皮生长因子的表达。 Pituitary tumor transforming gene (PTrG) can induce the expression of vascular endothelial growth factor (VEGF), one of the most important angiogenie growth factors for tumor angiogenesis, to promote tumor angiogenesis. It has been revealed that PTTG can transactivate the inhibitor of DNA binding-3 (ID3) and fibroblast growth factor-2 (FGF-2) by interacting with PTTG binding factor (PBF) and specificity protein 1 (Spl). PTTG can also regulate the transcription of matrix metalloproteinase-2 (MMP-2), thrombospondin-1 (TSP-1) and thioredoxin-1 (Trx-1) through other pathways, which are all involved in the mechanisms underlying the induction of VEGF expression by PTTG.
作者 曹华莉 郑敏
出处 《国际皮肤性病学杂志》 2012年第5期323-326,共4页 International Journal of Dermatology and Venereology
关键词 肿瘤 血管 垂体肿瘤 血管内皮生长因子 Neoplasms Blood vessels Pituitary neoplasms Vascular endothelial growth factor
  • 相关文献

参考文献22

  • 1Winnepenninckx V, Debiec-Rychter M, Belien JA, et al. Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma. Mod Pathol, 2006, 19 ( 9 ): 1170-1180.
  • 2杨萍,郑敏.血管内皮细胞生长因子家族及其受体与表皮黑素瘤的关系[J].国际皮肤性病学杂志,2009,35(6):385-387. 被引量:1
  • 3Hamid T, Malik MT, Kakar SS securin promotes tumorigenesis ceils. Mol Cancer, 2005, 4(1): 3.
  • 4Ectopic expression of PTTG1/ in human embryonic kidney Kim CS, Ying H, Willingham MC, et al. The pituitary tumor- transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer, Carcinogenesis, 2007, 28 (5): 932-939.
  • 5Kim DS, Franklyn JA, Boelaert K, et al. Pituitary tumor transforming gene (PTYG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. J Clin Endocrinol Metab, 2006, 91 ( 11 ): 4603-4611.
  • 6Tong Y, Tan Y, Zhou C, et al. Pituitary tumor transforming gene interacts with Spl to modulate G1/S cell phase transition. Oncogene, 2007, 26 (38 ): 5596-5605.
  • 7. Watkins RJ, Read ML, Smith VE, et al. Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res, 2010, 70(9): 3739-3749.
  • 8Chintharlapalli S, Papineni S, Lee SO, et al. Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins. Mol Carcinog, 2011, 50 (9): 655-667.
  • 9Kim DS, Franklyn JA, Stratford AL, et al. Pituitary tumor- transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. J Clin Endocrinol Metab, 2006, 91 (3): 1119-1128.
  • 10Chalkiadaki G, Nikitovic D, Berdiaki A, et al. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int J Biochem Cell Biol, 2009, 41(6): 1323-1331.

二级参考文献24

  • 1Einspahr JG, Thomas TL, Saboda K, et al. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression. Cancer, 2007, 110( 11 ): 2519-2527.
  • 2Demirkesen C, Buyukpinarbasili N, Ramazanoglu R, et al. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor. Pathology, 2006, 38(2 ): 132-137.
  • 3Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis. J Leukoc Biol, 2006, 80(4): 691-696.
  • 4i Bootie B, Blokx W, De Bacquer D, et al. The role of VEGF-C staining in predicting regional metastasis in melanoma. Vir chows Arch, 2008, 453( 3 ): 257-265.
  • 5Vihinen PP, Hilli J, Vuoristo MS, et al. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma. Acta Oncol, 2007, 46(5/: 678-684.
  • 6Depasquale I, Thompson WD. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. Histopathology, 2008, 52(4): 500-509.
  • 7Bolander A, Wagenius G, Larsson A, et al. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma. Anticancer Res, 2007, 27 (5A): 3211-3217.
  • 8Brennecke S, Deichmann M, Naeher H, et al. Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma. Melanoma Res, 2005, 15 (6): 515-522.
  • 9Pelletier F, Bermont L, Puzenat E, et al. Circulating vascular endothelial growth factor in cutaneous malignant melanoma. Br J Dermatol, 2005, 152(4): 685-689.
  • 10Rinderknecht M, Detmar M. Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol, 2008, 216( 2 ): 347-354.

同被引文献14

  • 1王任直.目前垂体腺瘤治疗中存在的问题及解决方法[J].中华医学杂志,2006,86(23):1585-1588. 被引量:31
  • 2李慧慧,李乐静,白淑平,常金.PTTG和VEGF在NSCLC中的表达及相关性研究[J].现代生物医学进展,2007,7(2):218-220. 被引量:2
  • 3McCabe C J,Boelaert K,Tannahill L A,Heaney A P,Stratford A L,Khaira J S,Hussain S,Sheppard M C,Franklyn J A,Gittoes N J L.Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. The Journal of clinical endocrinology and metabolism . 2002
  • 4Chesnokova Vera,Zonis Svetlana,Kovacs Kalman,Ben-Shlomo Anat,Wawrowsky Kolja,Bannykh Serguei,Melmed Shlomo.p21(Cip1) restrains pituitary tumor growth. Proceedings of the National Academy of Sciences of the United States of America . 2008
  • 5Arkadiusz Gertych,Anika Joseph,Ann Walts,Shikha Bose.??Automated Detection of Dual p16/Ki67 Nuclear Immunoreactivity in Liquid-Based Pap Tests for Improved Cervical Cancer Risk Stratification(J)Annals of Biomedical Engineering . 2012 (5)
  • 6Takeo Minematsu,Masanori Suzuki,Naoko Sanno,Susumu Takekoshi,Akira Teramoto,R. Yoshiyuki Osamura.??PTTG overexpression is correlated with angiogenesis in human pituitary adenomas(J)Endocrine Pathology . 2006 (2)
  • 7Li Hongyu,Shen Hongling,Xu Qian,Deng Dongrui,Wang Shixuan,Lu Yunping,Ma Ding.??Expression of pin1 and ki67 in cervical cancer and their significance(J)Journal of Huazhong University of Science and Technology [Medical Sciences] . 2006 (1)
  • 8Shi Xiaoyan,Yuan Xianglin,Tao Deding,Gong Jianping,Hu Guoqing.??Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry(J)Journal of Huazhong University of Science and Technology [Medical Sciences] . 2005 (2)
  • 9于顺江.抗VEGF肿瘤靶向治疗进展[J].癌症进展,2010,8(2):175-179. 被引量:8
  • 10程文,高建平,张征宇.微小RNA与肿瘤相关性研究[J].医学研究生学报,2011,24(2):203-207. 被引量:34

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部